Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.

Tianyu HeYuqing BaiHaodong CaiXiaojuan OuMin LiuWei YiJi-Dong Jia

Published in: Hepatology international (2018)

Treatment with lamivudine or telbivudine for active CHB in early pregnancy appears to be safe and effective for controlling maternal disease as well as interrupting MTCT.

Keyphrases

hiv infected patients
hepatitis b virus
physical activity
pregnancy outcomes
liver fibrosis
replacement therapy
weight gain